Quiz: Medicinal Product Knowledge — 35 Fragen

Detaillierte Fragen und Antworten

1. Which component of a medicinal product is directly responsible for its therapeutic action?

The excipient
The dosage form
The active ingredient
The packaging material

The active ingredient

Erklärung

The active ingredient is the natural, chemical, or biotechnological substance that produces the therapeutic action. An excipient supports administration and preservation but does not provide the therapeutic effect.

2. What is the primary role of an excipient in a medicinal product?

To facilitate formulation and administration
To produce the therapeutic effect
To diagnose a physiological disorder
To modify the drug target permanently

To facilitate formulation and administration

Erklärung

An excipient facilitates the formulation, administration, and preservation of the active ingredient while remaining inert toward the organism and the active ingredient.

3. Which description best defines a medicinal product?

A chemical that must act through the nervous system
A substance used exclusively to improve taste
A substance or composition with curative, preventive, diagnostic, or physiological-modifying effects
A substance manufactured only for hospital use

A substance or composition with curative, preventive, diagnostic, or physiological-modifying effects

Erklärung

A medicinal product may have curative or preventive properties, support diagnosis, or restore, correct, or modify physiological functions through pharmacological, immunological, or metabolic action.

4. Which feature distinguishes a pharmaceutical specialty from a magistral preparation?

It contains no active ingredient
It is prepared for a specifically identified patient
It is exempt from marketing authorization
It is prepared in advance industrially and marketed under a special name

It is prepared in advance industrially and marketed under a special name

Erklärung

A pharmaceutical specialty is industrially prepared in advance, packaged specifically, given a special name, and requires marketing authorization. A magistral preparation is made for an individual patient by prescription.

5. What distinguishes a generic medicine from a me-too medicine?

A generic is made for one patient, while a me-too is made for hospitals
A generic has the same active-ingredient composition and must demonstrate bioequivalence, while a me-too has a modified but similar structure
A generic requires no regulatory evidence, while a me-too requires bioequivalence testing
A generic has a modified structure, while a me-too exactly copies the reference active ingredient

A generic has the same active-ingredient composition and must demonstrate bioequivalence, while a me-too has a modified but similar structure

Erklärung

A generic medicine matches the reference specialty in active-ingredient composition and must demonstrate bioequivalence. A me-too medicine has a modified but similar structure.

6. When is a magistral preparation made?

When a medicine is being prepared for wholesale distribution
When a pharmaceutical company wants to introduce a new reference specialty
When a specific patient needs a medicine for which no suitable authorized specialty is available
When an industrial medicine is already suitable and authorized for the patient

When a specific patient needs a medicine for which no suitable authorized specialty is available

Erklärung

A magistral preparation is produced according to a prescription for a specific patient when no suitable authorized pharmaceutical specialty is available.

7. Which sequence best represents the main stages of drug discovery?

Target selection, bioactive-molecule design, library synthesis, structure–activity analysis, and hit optimization
Clinical approval, patient selection, packaging, library synthesis, and marketing
Excipient selection, diagnosis, manufacturing, dispensing, and target elimination
Target selection, sterilization, wholesale distribution, bioequivalence testing, and packaging

Target selection, bioactive-molecule design, library synthesis, structure–activity analysis, and hit optimization

Erklärung

Drug discovery proceeds from selecting a target through designing bioactive molecules, synthesizing compound libraries, analyzing structure–activity relationships, and structurally optimizing a hit.

8. Which of the following is a recognized drug target?

A prescription form
A tablet coating
A storage container
An ion channel

An ion channel

Erklärung

Drug targets include receptors, enzymes, transport molecules, ion channels, idiosyncratic targets, and nucleic acids. The other options are product or administrative components, not biological targets.

9. A researcher tests a compound in cultured cells outside any living organism. How should this experiment be classified?

A clinical experiment
A pharmacovigilance study
An in vitro experiment
An in vivo experiment

An in vitro experiment

Erklärung

In vitro experiments are performed outside a living organism, such as in cultured cells. In vivo experiments are conducted inside a living organism.

10. What is the key difference between a hit and a lead in drug discovery?

A hit is tested only in humans, whereas a lead is tested only in animals
A hit is an excipient, whereas a lead is an active ingredient
A hit has no biological activity, whereas a lead is the first active molecule discovered
A hit is a promising but insufficiently optimized molecule, whereas a lead has an improved activity profile suitable for preclinical progression

A hit is a promising but insufficiently optimized molecule, whereas a lead has an improved activity profile suitable for preclinical progression

Erklärung

A hit is a first molecule with promising biological activity but insufficient optimization to become a medicine. A lead is more optimized, has an improved activity profile, and can progress toward preclinical development.

11. What does molecular modeling aim to produce under defined conditions?

A validated manufacturing process for a medicine
A plausible three-dimensional representation of a molecule
A complete clinical profile of a drug candidate
A patentable analogue of an existing medicine

A plausible three-dimensional representation of a molecule

Erklärung

Molecular modeling uses computational chemistry and graphical visualization to investigate molecular structures and properties and produce a plausible three-dimensional representation under defined conditions.

12. Which sequence correctly describes the main steps of homology modeling?

Measure drug absorption, calculate toxicity, synthesize metabolites, and determine dosage
Identify a lead, conduct clinical trials, file a patent, and request marketing authorization
Search a sequence database, crystallize the protein, remove amino acids, and market the drug
Find a structural analogue, align sequences, build by residue replacement, minimize energy, and validate

Find a structural analogue, align sequences, build by residue replacement, minimize energy, and validate

Erklärung

Homology modeling uses a structurally known sequence analogue, aligns the sequences, replaces differing amino acids to build the model, and then performs energy minimization and validation.

13. What is the defining role of a pharmacophore in molecular recognition?

It is a database containing experimentally determined protein structures
It is a computational procedure that minimizes the energy of a molecular model
It is the portion of a molecule that primarily determines its pharmacokinetic behavior
It is the spatial arrangement of chemical functions required for biological activity

It is the spatial arrangement of chemical functions required for biological activity

Erklärung

A pharmacophore is the spatial arrangement of chemical functions necessary for biological activity. Other parts of the molecular key mainly contribute to pharmacokinetics.

14. Which description best defines a me-too drug?

A reformulated product that differs only in packaging and administration instructions
A compound with a completely new mechanism unrelated to existing medicines
A medicine containing exactly the same active ingredient as its reference product
A structurally related new active ingredient with a similar mechanism and sufficient differences for patenting

A structurally related new active ingredient with a similar mechanism and sufficient differences for patenting

Erklärung

A me-too drug is structurally close to an original medicine and acts through a similar mechanism, but differs sufficiently in structure to be patentable. A generic has the same active-ingredient composition as the reference.

15. Which structural features are present in salicylic acid?

A pyridine ring, an ester function, and an ether function
A cyclohexane ring, an amino function, and a thiol function
A benzene ring, an amide function, and a ketone function
A benzene ring, a carboxylic-acid function, and a hydroxyl function

A benzene ring, a carboxylic-acid function, and a hydroxyl function

Erklärung

Salicylic acid, the lead compound of the arylcarboxylic-acid series, contains a benzene ring, a carboxylic-acid function, and a hydroxyl function.

16. Which sequence represents the major stages of drug development?

Lead identification, formulation design, advertising approval, and commercial distribution
Clinical testing, sequence analysis, structural modeling, and laboratory screening
In vitro research, in vivo preclinical development, clinical development, and marketing authorization
Patent monitoring, analogue synthesis, competitor selection, and product marketing

In vitro research, in vivo preclinical development, clinical development, and marketing authorization

Erklärung

Drug development progresses through in vitro research and development, in vivo preclinical development, clinical development in humans, and marketing authorization when the molecule is sufficiently safe and effective.

17. What is the approximate overall duration and cost of drug research and development?

About 2 years and approximately one million euros
About 10 years and more than one billion euros
About 5 years and approximately ten million euros
About 20 years and approximately one hundred million euros

About 10 years and more than one billion euros

Erklärung

Drug research and development lasts approximately 10 years and costs more than one billion euros overall. The resulting product is protected by a patent lasting 20 years.

18. How does the number of subjects generally change across clinical development from phase I to phase III?

It increases from fewer than 100 to several thousand
It increases only after phase III is completed
It remains below 100 throughout all three phases
It decreases from several thousand to fewer than 100

It increases from fewer than 100 to several thousand

Erklärung

Clinical development uses progressively larger groups, ranging from fewer than 100 subjects in phase I to several thousand in phase III.

19. Which primary objective is characteristic of a phase I clinical trial?

Confirming benefit-risk in several thousand ill patients
Comparing the medicine with existing treatments after marketing
Defining the indication in special patient populations
Determining maximum tolerated dose and pharmacokinetic behavior

Determining maximum tolerated dose and pharmacokinetic behavior

Erklärung

Phase I examines the maximum tolerated dose, pharmacokinetics, and, when possible, pharmacodynamics, usually in fewer than 100 healthy volunteers.

20. A study enrolls fewer than 500 volunteer patients to investigate efficacy, toxicity, and the dose-effect relationship. Which phase is it?

Phase IV
Phase III
Phase I
Phase II

Phase II

Erklärung

Phase II evaluates potential efficacy and toxicity, the dose-effect relationship, and the optimal dose in fewer than 500 volunteer patients.

21. Which outcome is most directly associated with a successful phase III clinical trial?

Post-marketing assessment of pharmacoeconomics
Definition of the indication and support for marketing authorization
Selection of a maximum tolerated dose before patient testing
Initial measurement of pharmacokinetics in healthy volunteers

Definition of the indication and support for marketing authorization

Erklärung

Phase III evaluates the benefit-risk ratio, defines the indication and special populations, and can support marketing authorization.

22. Which relationship distinguishes pharmacokinetics from pharmacodynamics?

Pharmacokinetics studies manufacturing, while pharmacodynamics studies distribution
Pharmacokinetics links dose to concentration, while pharmacodynamics links concentration to effect
Pharmacokinetics links concentration to effect, while pharmacodynamics links dose to concentration
Pharmacokinetics measures toxicity, while pharmacodynamics measures drug purity

Pharmacokinetics links dose to concentration, while pharmacodynamics links concentration to effect

Erklärung

Pharmacokinetics describes what the organism does to the medicine through the dose-concentration relationship; pharmacodynamics describes what the medicine does to the organism through concentration and effect.

23. Which sequence correctly represents the ADME pathway?

Distribution, absorption, elimination, metabolism
Absorption, distribution, metabolism, elimination
Absorption, metabolism, distribution, elimination
Metabolism, absorption, distribution, elimination

Absorption, distribution, metabolism, elimination

Erklärung

ADME stands for absorption, distribution, metabolism, and elimination in that order.

24. A medicine crosses a membrane down its concentration gradient without energy or a transporter, and the process does not become saturated. Which mechanism is involved?

Protein binding
Passive diffusion
Active transport
Facilitated diffusion

Passive diffusion

Erklärung

Passive diffusion follows a concentration gradient without energy or a transporter and is not saturable. Facilitated diffusion instead uses saturable transporters.

25. What is the main sequence of hepatic drug metabolism?

Phase I elimination followed by phase II distribution
Phase I conjugation followed by phase II oxidation
Phase I functionalization followed by phase II conjugation
Phase I protein binding followed by phase II absorption

Phase I functionalization followed by phase II conjugation

Erklärung

Drug metabolism mainly occurs in the liver, where phase I functionalization involves oxidation, reduction, or hydrolysis, followed by phase II conjugation with endogenous polar molecules.

26. What do analytical studies for medicine quality control assess?

Both what is present and how much is present
Only the therapeutic effect in patients
Only whether the medicine is absorbed rapidly
Only the medicine's manufacturing cost

Both what is present and how much is present

Erklärung

Medicine quality requires assessment of quality, safety, and efficacy, while analytical quality control determines both the identity or presence of substances and their quantities.

27. Which organization-and-level pairing is correct for medicine regulation and standards?

WHO nationally in France, Council of Europe internationally, ANSM in Europe
WHO through French national rules, Council of Europe internationally, ANSM through the European Pharmacopoeia
WHO through the European Pharmacopoeia, Council of Europe nationally in France, ANSM internationally
WHO internationally, Council of Europe through the European Pharmacopoeia, ANSM nationally in France

WHO internationally, Council of Europe through the European Pharmacopoeia, ANSM nationally in France

Erklärung

The WHO acts internationally, the Council of Europe operates at the European level through the European Pharmacopoeia, and France's ANSM applies the framework nationally.

28. What is the purpose of Good Manufacturing Practices?

To compare a marketed medicine with every existing treatment
To ensure products are manufactured and controlled uniformly according to appropriate standards
To replace analytical testing with visual inspection
To determine whether a medicine produces a therapeutic effect in a clinical trial

To ensure products are manufactured and controlled uniformly according to appropriate standards

Erklärung

Good Manufacturing Practices are quality-assurance elements designed to ensure uniform manufacture and control according to standards appropriate to the product's use and its marketing authorization. The definition is attributed to the WHO.

29. Which activity is an analytical control function?

Qualifying and quantifying substances while detecting impurities
Defining a medicine's therapeutic indication
Estimating the medicine's commercial demand
Choosing the patient population for a clinical trial

Qualifying and quantifying substances while detecting impurities

Erklärung

Analytical controls determine what is present, how much is present, identify substances, and detect impurities or related substances above permitted limits.

30. Which description best defines a galenic form?

The chemical mechanism responsible for a medicine's effect
The schedule specifying how often a medicine is taken
The physical presentation of a medicine, such as a tablet or ointment
The pathway by which a medicine enters the organism

The physical presentation of a medicine, such as a tablet or ointment

Erklärung

A galenic form is the concrete physical presentation of a medicine. It differs from the route of administration, which describes how the medicine enters the organism.

31. Which administration route is classified as parenteral?

Intramuscular administration
Oral administration
Cutaneous application without skin penetration
Sublingual administration

Intramuscular administration

Erklärung

Parenteral administration penetrates through the skin and includes intramuscular, intravenous, subcutaneous, and intradermal routes. Oral and nonpenetrating cutaneous administration are not parenteral.

32. Which statement correctly describes who may prescribe medicines?

Pharmacists generally prescribe all medicines because they dispense them
Only physicians may prescribe any healthcare product or medical device
Physicians generally prescribe medicines, while other professionals may prescribe within defined legal scopes
Midwives may prescribe all medicines without limits related to their practice

Physicians generally prescribe medicines, while other professionals may prescribe within defined legal scopes

Erklärung

Physicians are primary prescribers, while midwives, dental surgeons, and physiotherapists may prescribe within specific scopes. Pharmacists generally dispense medicines and have limited prescribing authority, such as for certain vaccines.

33. What should guide a prescription when selecting and describing a medicine for a patient?

The patient's preference alone, regardless of authorization or clinical risks
The medicine's advertising materials and the prescriber's usual personal preference
The marketing authorization, product characteristics, benefit-risk assessment, and relevant patient information
A treatment choice outside the marketing authorization as the standard approach

The marketing authorization, product characteristics, benefit-risk assessment, and relevant patient information

Erklärung

Prescribing should follow the marketing authorization and Summary of Product Characteristics while considering benefit-risk and patient-specific information such as pathology, history, allergies, and previous treatments.

34. Which item must appear immediately below the last line of an ordonnance?

The patient's allergy history
The pharmacist's dispensing instructions
The prescriber's signature
The medicine's marketing authorization number

The prescriber's signature

Erklärung

An ordonnance must contain several identification and treatment details, and the prescriber's signature must appear immediately below the last line.

35. Which type of ordonnance is specifically used for narcotics?

A simple ordonnance
An exceptional-medicine CERFA form
A secured ordonnance
A two-zone ordonnance

A secured ordonnance

Erklärung

The four ordonnance types include simple forms, secured forms for narcotics, two-zone forms for certain long-term conditions, and exceptional-medicine forms printed on CERFA documents.

Mit Karteikarten lernen

Merke dir die Antworten mit 74 Karteikarten zu Medicinal Product Knowledge.

What is an active ingredient in a medicinal product?

It is the substance responsible for the therapeutic action.

What role does an excipient play in a medicinal product?

It facilitates administration, formulation, and preservation of the active ingredient.

What must an excipient be toward the organism and active ingredient?

It must be inert.

Karteikarten ansehen →

Lernzettel studieren

Lies den vollständigen Lernzettel zu Medicinal Product Knowledge.

Lernzettel ansehen →

Similar courses

Erstelle deine eigenen Quizze

Importiere deinen Kurs und die KI erstellt in 30 Sekunden Quizze mit Korrekturen.

Quiz-Generator